{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:24:22Z","timestamp":1783027462284,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jri.2026.104887","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:40:12Z","timestamp":1775230812000},"page":"104887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Construction and validation of a risk prediction model for recurrent pregnancy losses in patients with positive antiphospholipid antibodies"],"prefix":"10.1016","volume":"175","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jri.2026.104887_bib1","first-page":"84","article-title":"Multiple intrathoracic thrombosis detected on ct scan in patient with antiphospholipid antibody syndrome: case report","volume":"14","author":"Bekti","year":"2023","journal-title":"Sains Med."},{"issue":"4","key":"10.1016\/j.jri.2026.104887_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10067-023-06843-x","article-title":"Recurrent miscarriage and low-titer antiphospholipid antibodies","volume":"43","author":"Chen","year":"2024","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.jri.2026.104887_bib3","first-page":"10","article-title":"Volume","author":"Cugno","year":"2019","journal-title":"Coagul. Ski. Autoimmun."},{"issue":"6","key":"10.1016\/j.jri.2026.104887_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.2006.061671","article-title":"Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases","volume":"66","author":"G\u00f3mez-Puerta","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jri.2026.104887_bib5","first-page":"1033","article-title":"Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome","volume":"55","author":"Hong","year":"2023","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.jri.2026.104887_bib6","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.jri.2026.104887_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1477-7827-1-111","article-title":"Thrombophilia and pregnancy","volume":"1","author":"Kupferminc","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"10","key":"10.1016\/j.jri.2026.104887_bib8","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/humrep\/deae181","article-title":"A nomogram and risk stratification to predict subsequent pregnancy loss in patients with recurrent pregnancy loss","volume":"39","author":"Li","year":"2024","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jri.2026.104887_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatol. (Oxf. )"},{"issue":"2","key":"10.1016\/j.jri.2026.104887_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.jri.2026.104887_bib11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jri.2026.104887_bib12","first-page":"279","article-title":"Immunologic factors and genomic considerations in recurrent pregnancy loss: a review","volume":"10","author":"Montazeri","year":"2023","journal-title":"Int J. Med Lab"},{"issue":"3","key":"10.1016\/j.jri.2026.104887_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s43032-023-01388-5","article-title":"Preconception Non-criteria Antiphospholipid Antibodies and Risk of Subsequent Early Pregnancy Loss: a Retrospective Study","volume":"31","author":"Mu","year":"2024","journal-title":"Reprod. Sci."},{"issue":"3","key":"10.1016\/j.jri.2026.104887_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13837","article-title":"Predicting risk of subsequent pregnancy loss among women with recurrent pregnancy loss: An immunological factor-based multivariable model","volume":"91","author":"Mu","year":"2024","journal-title":"Am. J. Reprod. Immunol."},{"issue":"9535","key":"10.1016\/j.jri.2026.104887_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"issue":"9751","key":"10.1016\/j.jri.2026.104887_bib16","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2026.104887_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1447-0756.2004.00206.x","article-title":"Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss","volume":"30","author":"Sugi","year":"2004","journal-title":"J. Obstet. Gynaecol. Res"},{"issue":"9","key":"10.1016\/j.jri.2026.104887_bib18","first-page":"653","article-title":"Expert Consensus on the Diagnosis and Treatment of Recurrent Miscarriage (2022)","volume":"57","author":"The Reproductive Medicine Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association, the Expert Consensus Writing Group for the Diagnosis and Treatment of Recurrent Miscarriage Association","year":"2022","journal-title":"Chin. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.jri.2026.104887_bib19","first-page":"432","article-title":"Changes in coagulation function indicators and their clinical significance in patients with recurrent miscarriage and positive antiphospholipid antibodies","volume":"39","author":"Wang","year":"2023","journal-title":"Chin. J. Pract. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.jri.2026.104887_bib20","first-page":"132","article-title":"immune indicators in early pregnancy and non-pregnant women with positive aPL","volume":"40","author":"Wang","year":"2024","journal-title":"J. Pract. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.jri.2026.104887_bib21","first-page":"368","article-title":"Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women","volume":"47","author":"Wu","year":"2021"},{"key":"10.1016\/j.jri.2026.104887_bib22","article-title":"Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis","volume":"2022","author":"Xu","year":"2022","journal-title":"Int J. Clin. Pr."},{"issue":"4","key":"10.1016\/j.jri.2026.104887_bib23","first-page":"2350","article-title":"The association of AT-III and D-Dimer with unexplained recurrent spontaneous abortion and their diagnostic value for prethrombotic state","volume":"14","author":"Ye","year":"2022","journal-title":"Am. J. Transl. Res"},{"issue":"13","key":"10.1016\/j.jri.2026.104887_bib24","first-page":"1038","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"97","author":"Ye","year":"2017","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.jri.2026.104887_bib25","first-page":"670","article-title":"A predictive model of early pregnancy abortion in unknown recurrent abortion was constructed based on autoantibody and lymphocyte immunophenotype","volume":"47","author":"ZHANG","year":"2024","journal-title":"Int. J. Immunol."},{"issue":"5","key":"10.1016\/j.jri.2026.104887_bib26","first-page":"1892","article-title":"Coagulation markers in antiphospholipid antibody-positive women: comparison between non-pregnant and first-trimester pregnant states","volume":"49","author":"Zhao","year":"2023","journal-title":"J. Obstet. Gynaecol. Res."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:12:27Z","timestamp":1783026747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037826000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S0165037826000562"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2026.104887","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and validation of a risk prediction model for recurrent pregnancy losses in patients with positive antiphospholipid antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2026.104887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104887"}}